TY - JOUR
T1 - Allosteric interactions between the binding sites of receptor agonists and guanine nucleotides
T2 - A comparative study of the 5-hydroxytryptamine(1A) and adenosine A1 receptor systems in rat hippocampal membranes
AU - Mahle, C. D.
AU - Wiener, H. L.
AU - Yocca, F. D.
AU - Maayani, S.
PY - 1992
Y1 - 1992
N2 - The ternary complex formed between agonist, receptor and guanine nucleotide binding protein and its destabilization by guanine nucleotides (GN) was utilized to study early events in signal transduction, by characterizing the allosteric interactions between agonist and GN binding to the receptor/guanine nucleotide binding protein, G complex for adenosine A1 and 5-hydroxytryptamine(1A) receptors. The functional interaction between the ternary complex and GTP was examined by assaying adenylyl cyclase activity. Binding of a full adenosine A1 agonist {[3H]-R-(-)-N6-(2- phenylisopropyl)adenosine}, and a full {(±)-[3H]-8- hydroxydipropylaminotetralin} and partial {[3H]-8-[2-[4-(2- methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspirol[4.5]-decane-7,9-dione} 5- hydroxytryptamine(1A) agonist was examined in relation to the binding of GN. The amount of ternary complex formed depended upon receptor type and drug relative efficacy. The ratio between the drug's EC50 value (adenylyl cyclase) and dissociation constant (binding) was also receptor and drug relative efficacy dependent. 5'-Guanylylimidodiphosphate (100 μM) caused an approximately 50% decrease in the B(max) for all drugs without affecting K(d) values. 5'-Guanylylimidodiphosphate and guanosine 5'-O-(3-thiotriphosphate) attenuated [3H]-agonist binding in a concentration-dependent and saturable manner, with IC50 values increased 2- to 6-fold with increasing receptor occupancy. IC50 values were approximately one-tenth lower at the 5- hydroxytryptamine(1A) receptor than adenosine A1 receptor; similar values were obtained for inhibition of (±)-[3H]-8-hydroxydipropylaminotetralin and [3H]-8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspirol[4.5]- decane-7,9-dione binding, suggesting an independence of agonist efficacy. We propose that the stabilization of the ternary complex by hormone binding, measured by B(max) values, is related to drug-relative efficacy, thus the amount of ternary complex available for destabilization by GN is greater for the more efficacious agonist. This is translated into greater relative efficacy observed in the maximal inhibition of adenylyl cyclase.
AB - The ternary complex formed between agonist, receptor and guanine nucleotide binding protein and its destabilization by guanine nucleotides (GN) was utilized to study early events in signal transduction, by characterizing the allosteric interactions between agonist and GN binding to the receptor/guanine nucleotide binding protein, G complex for adenosine A1 and 5-hydroxytryptamine(1A) receptors. The functional interaction between the ternary complex and GTP was examined by assaying adenylyl cyclase activity. Binding of a full adenosine A1 agonist {[3H]-R-(-)-N6-(2- phenylisopropyl)adenosine}, and a full {(±)-[3H]-8- hydroxydipropylaminotetralin} and partial {[3H]-8-[2-[4-(2- methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspirol[4.5]-decane-7,9-dione} 5- hydroxytryptamine(1A) agonist was examined in relation to the binding of GN. The amount of ternary complex formed depended upon receptor type and drug relative efficacy. The ratio between the drug's EC50 value (adenylyl cyclase) and dissociation constant (binding) was also receptor and drug relative efficacy dependent. 5'-Guanylylimidodiphosphate (100 μM) caused an approximately 50% decrease in the B(max) for all drugs without affecting K(d) values. 5'-Guanylylimidodiphosphate and guanosine 5'-O-(3-thiotriphosphate) attenuated [3H]-agonist binding in a concentration-dependent and saturable manner, with IC50 values increased 2- to 6-fold with increasing receptor occupancy. IC50 values were approximately one-tenth lower at the 5- hydroxytryptamine(1A) receptor than adenosine A1 receptor; similar values were obtained for inhibition of (±)-[3H]-8-hydroxydipropylaminotetralin and [3H]-8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspirol[4.5]- decane-7,9-dione binding, suggesting an independence of agonist efficacy. We propose that the stabilization of the ternary complex by hormone binding, measured by B(max) values, is related to drug-relative efficacy, thus the amount of ternary complex available for destabilization by GN is greater for the more efficacious agonist. This is translated into greater relative efficacy observed in the maximal inhibition of adenylyl cyclase.
UR - http://www.scopus.com/inward/record.url?scp=0026969020&partnerID=8YFLogxK
M3 - Article
C2 - 1469633
AN - SCOPUS:0026969020
SN - 0022-3565
VL - 263
SP - 1275
EP - 1284
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 3
ER -